NF-κB in cancer: from innocent bystander to major culprit View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2002-04

AUTHORS

Michael Karin, Yixue Cao, Florian R. Greten, Zhi-Wei Li

ABSTRACT

Key Points Nuclear factor of κB (NF-κB) is a transcriptional regulator that is made up of different protein dimers that bind a common sequence motif known as the κB site. Although NF-κB target genes have been most intensely studied for their involvement in immunity and inflammation, this transcription factor also regulates cell proliferation, apoptosis and cell migration. Therefore, it is not surprising that NF-κB has been shown to be constitutively activated in several types of cancer cell. NF-κB activity is tightly controlled by several regulatory proteins, and disruption of this process has been associated with various haematological malignancies, as well as epithelial tumours such as breast cancer. A causal connection between inflammation and cancer has been suspected for many years. Because NF-κB becomes activated in response to inflammatory stimuli and its constitutive activation has been associated with cancer, NF-κB might also serve as the missing link between these two processes. Numerous inhibitors of NF-κB are therefore under development or have been developed. Because of the widespread importance of this factor, it has been difficult to develop NF-κB inhibitors that act specifically in cancer cells. Learning more about the complicated process of NF-κB regulation should lead to better therapeutic approaches to target the factor in specific cell types. More... »

PAGES

301-310

References to SciGraph publications

  • 2000-02. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling in NATURE
  • 2002-03-01. NF-κB at the crossroads of life and death in NATURE IMMUNOLOGY
  • 2000-03. Interleukin-1 polymorphisms associated with increased risk of gastric cancer in NATURE
  • 2001-06. Specific protection against breast cancers by cyclin D1 ablation in NATURE
  • 1999-08-12. Overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma is regulated by constitutively activated RelA in ONCOGENE
  • 1999-06-03. The Bcl-3 oncoprotein acts as a bridging factor between NF-κB/Rel and nuclear co-regulators in ONCOGENE
  • 1999-10-26. Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-κB activation via the NIK/IKK signalling complex in ONCOGENE
  • 1998-11. The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β in NATURE
  • 1997-02-20. Identification of a tumor-associated mutant form of the NF-κB RelA gene with reduced DNA-binding and transactivating activities in ONCOGENE
  • 1998-05-07. Lymphadenopathy, splenomegaly, and altered immunoglobulin production in BCL3 transgenic mice in ONCOGENE
  • 1999-01-28. Molecular mechanisms of constitutive NF-κB/Rel activation in Hodgkin/Reed-Sternberg cells in ONCOGENE
  • 1999-10-13. A novel gene, MALT1 at 18q21, is involved in t(11;18) (q21;q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue in ONCOGENE
  • 2001-10-25. Malignant transformation of primary chicken spleen cells by human transcription factor c-Rel in ONCOGENE
  • 2001-02-15. NF-kappaB, p38 MAPK and JNK are highly expressed and active in the stroma of human colonic adenomatous polyps in ONCOGENE
  • 1998-10. COX-2 and colon cancer in INFLAMMATION RESEARCH
  • 2002-01-01. Helicobacter pylori and gastrointestinal tract adenocarcinomas in NATURE REVIEWS CANCER
  • 2000-02-24. Selective activation of NF-κB subunits in human breast cancer: potential roles for NF-κB2/p52 and for Bcl-3 in ONCOGENE
  • 2001-03-15. Her-2/neu overexpression induces NF-κB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IκB-α that can be inhibited by the tumor suppressor PTEN in ONCOGENE
  • 2001-10-11. P53 plays a protective role against UV- and cisplatin-induced apoptosis in transcription-coupled repair proficient fibroblasts in ONCOGENE
  • 1999-04. Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB in NATURE MEDICINE
  • 1999-11-22. Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel in ONCOGENE
  • 1996-09. Local administration of antisense phosphorothiate olignucleotides to the p65 subunit of NF–κB abrogates established experimental colitis in mice in NATURE MEDICINE
  • Journal

    TITLE

    Nature Reviews Cancer

    ISSUE

    4

    VOLUME

    2

    Related Patents

  • Methods And Compositions Involving Microrna
  • Predictors For Cancer Treatment
  • Micrornas Differentially Expressed In Cervical Cancer And Uses Thereof
  • Methods For Diagnosis, Prognosis And Treatment Of Primary And Metastatic Basal-Like Breast Cancer And Other Cancer Types
  • Methods And Compositions Involving Mirna And Mirna Inhibitor Molecules
  • Phenyl Thiophene Carboxamide Compounds As Inhibitors Of The Enzyme Ikk-2
  • Monocyclic Cyanoenones And Methods Of Use Thereof
  • Methods And Compositions Involving Mir-135b For Distinguishing Pancreatic Cancer From Benign Pancreatic Disease
  • Prodrug Compositions, Prodrug Nanoparticles, And Methods Of Use Thereof
  • Methods And Compositions Involving Microrna
  • Therapeutic Curcumin Derivatives
  • Pharmaceutical Or Medicinal Preparation Comprising A Combination Of Two Herbs Emblica Officinalis (Nelli) And Tinospora Cordifolia (Rasakinda) To Be Administered Together For Targeted Stimulation Of Immue System For Prophylaxis And Treatment Of Oral Cancer
  • Methods And Compositions Involving Mirna And Mirna Inhibitor Molecules
  • Identifying Modulators Of Mucin/Inhibitory Kappa-B Protein Binding; Treating And Preventing Inflammatory And Autoimmune Disorders
  • Methods And Compositions Involving Microrna
  • Prodrug Compositions, Prodrug Nanoparticles, And Methods Of Use Thereof
  • Modification Of Recombinant Adenovirus With Immunogenic Plasmodium Circumsporozoite Protein Epitopes
  • Pharmaceutical Component And Use Thereof For Inhibiting The Genesis And Metastasis Of A Breast Cancer Tumor
  • Anti-Tnf Induced Apoptosis (Atia) Diagnostic Markers And Therapies
  • Methods And Compositions Involving Microrna
  • Method Of Enhancing An Antitumor T Cell Response By Administering An Anti-Il-6 Receptor Antibody
  • Neuroinvasion Inhibitor
  • Particles For Imaging
  • Methods And Compositions Involving Mirna And Mirna Inhibitor Molecules
  • Thiophene Carboxamides As Inhibitors Of The Enzyme Ikk-2
  • Methods And Compositions For Isolating, Enriching, And/Or Labeling Mirna Molecules And For Preparing And Using Arrays Or Other Detection Techniques For Mirna Analysis. Moreover, The Present Invention Concerns Methods And Compositions For Generating Mirna Profiles And Employing Such Profiles
  • Nuclear Factor Kappa B Pathway Inhibitor Composition And Use Of Same
  • Transcription Modulator Compositions
  • Administering Synthetic Mirna Or Inhibitor As An Anticarcinogenic Agent That Protects Noncancerous Cells And Is Effective Against Chemo- And Radiation Resistant Cancer Cells; Breast, Colon, Thyroid And Lung Cancers; Antimetastasis Agents
  • Compositions And Methods Related To Mirna Modulation Of Neovascularization Or Angiogenesis
  • Cancer Therapy Via Selective Uptake Of Specialized Nanoparticles In Cancer Cells
  • 8-Substituted Isoquinoline Derivative And The Use Thereof
  • Methods Of Inhibiting The Interaction Between S100 And The Receptor For Advanced Glycation End-Products
  • Agents For Suppressing Damage To Transplanted Islets After Islet Transplantation
  • Compositions And Methods Related To Mirna Modulation Of Neovascularization Or Angiogenesis
  • Micrornas Differentially Expressed In Cervical Cancer And Uses Thereof
  • 2-[(Aminocarbonyl)Amino]-5-(4-{[2,2,2-Trifluoroethyl)Amino]Methyl}Phenyl)Thiophene-3-Carboxamide; I Kappa B Kinase-1(Ikk-1) Inhibitors; Asthma, Rheumatoid Arthritis, Psoriasis, Inflammatory Bowel Disease, Multiple Sclerosis, Chronic Obstructive Pulmonary Disease, Bone Resorptive Disease, Osteoarthritis
  • Ligand Directed Toroidal Nanoparticles For Therapy And Diagnostic Imaging
  • Methods For Treating Myocardial Infarction Comprising Administering An Il-6 Inhibitor
  • Methods Of Treating Alport Syndrome Using Bardoxolone Methyl Or Analogs Thereof
  • Methods For Suppressing Acute Rejection Of A Heart Transplant
  • Methods For Treating A Disease Involving Choroidal Neovascularization By Administering An Il-6 Receptor Antibody
  • Monocyclic Cyanoenones And Methods Of Use Thereof
  • Methods And Compositions Involving Mirna And Mirna Inhibitor Molecules
  • Methods And Compositions Involving Mirna And Mirna Inhibitor Molecules
  • Methods Of Treating Alport Syndrome Using Bardoxolone Methyl Or Analogs Thereof
  • Chronic Rejection Inhibitor
  • Prodrug Compositions, Prodrug Nanoparticles, And Methods Of Use Thereof
  • Methods And Compositions Involving Mirna And Mirna Inhibitor Molecules
  • Methods And Compositions Involving Mir-135b For Distinguishing Pancreatic Cancer From Benign Pancreatic Disease
  • Methods And Compositions Involving Mirna And Mirna Inhibitor Molecules
  • Method For Promoting Muscle Regeneration By Administering An Antibody To The Il-6 Receptor
  • Mir-124 Regulated Genes And Pathways As Targets For Therapeutic Intervention
  • Therapeutic Curcumin Derivatives
  • Transcription Modulator Compositions
  • Methods Of Using Thrombin Derivatives To Treat Medulloblastoma
  • Method And Compositions Involving Microrna
  • Antithrombotic Nanoparticle
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/nrc780

    DOI

    http://dx.doi.org/10.1038/nrc780

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1024581782

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/12001991


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Oncology and Carcinogenesis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Lymphatic Diseases", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Models, Biological", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "NF-kappa B", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Neoplasms", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Signal Transduction", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Department of Pharmacology, Laboratory of Gene Regulation and Signal Transduction, School of Medicine, University of California San Diego, 9500 Gilman Drive, 92093, La Jolla, California, USA", 
              "id": "http://www.grid.ac/institutes/grid.266100.3", 
              "name": [
                "Department of Pharmacology, Laboratory of Gene Regulation and Signal Transduction, School of Medicine, University of California San Diego, 9500 Gilman Drive, 92093, La Jolla, California, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Karin", 
            "givenName": "Michael", 
            "id": "sg:person.0706540600.87", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0706540600.87"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Pharmacology, Laboratory of Gene Regulation and Signal Transduction, School of Medicine, University of California San Diego, 9500 Gilman Drive, 92093, La Jolla, California, USA", 
              "id": "http://www.grid.ac/institutes/grid.266100.3", 
              "name": [
                "Department of Pharmacology, Laboratory of Gene Regulation and Signal Transduction, School of Medicine, University of California San Diego, 9500 Gilman Drive, 92093, La Jolla, California, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Cao", 
            "givenName": "Yixue", 
            "id": "sg:person.01310256550.39", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01310256550.39"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Pharmacology, Laboratory of Gene Regulation and Signal Transduction, School of Medicine, University of California San Diego, 9500 Gilman Drive, 92093, La Jolla, California, USA", 
              "id": "http://www.grid.ac/institutes/grid.266100.3", 
              "name": [
                "Department of Pharmacology, Laboratory of Gene Regulation and Signal Transduction, School of Medicine, University of California San Diego, 9500 Gilman Drive, 92093, La Jolla, California, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Greten", 
            "givenName": "Florian R.", 
            "id": "sg:person.01356730670.31", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01356730670.31"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Pharmacology, Laboratory of Gene Regulation and Signal Transduction, School of Medicine, University of California San Diego, 9500 Gilman Drive, 92093, La Jolla, California, USA", 
              "id": "http://www.grid.ac/institutes/grid.266100.3", 
              "name": [
                "Department of Pharmacology, Laboratory of Gene Regulation and Signal Transduction, School of Medicine, University of California San Diego, 9500 Gilman Drive, 92093, La Jolla, California, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Li", 
            "givenName": "Zhi-Wei", 
            "id": "sg:person.01271704732.87", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271704732.87"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/ni0302-221", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1045237056", 
              "https://doi.org/10.1038/ni0302-221"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.onc.1202717", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1017468422", 
              "https://doi.org/10.1038/sj.onc.1202717"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nm0996-998", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1014827861", 
              "https://doi.org/10.1038/nm0996-998"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.onc.1200895", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1026178102", 
              "https://doi.org/10.1038/sj.onc.1200895"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.onc.1203412", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1046200001", 
              "https://doi.org/10.1038/sj.onc.1203412"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.onc.1204162", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1031069682", 
              "https://doi.org/10.1038/sj.onc.1204162"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/35082500", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1034302480", 
              "https://doi.org/10.1038/35082500"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.onc.1204901", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1011576997", 
              "https://doi.org/10.1038/sj.onc.1204901"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrc703", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1029485597", 
              "https://doi.org/10.1038/nrc703"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.onc.1203018", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1043782984", 
              "https://doi.org/10.1038/sj.onc.1203018"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.onc.1202833", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1021502107", 
              "https://doi.org/10.1038/sj.onc.1202833"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/7410", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1016228251", 
              "https://doi.org/10.1038/7410"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.onc.1204257", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1043172496", 
              "https://doi.org/10.1038/sj.onc.1204257"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/35000501", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1010898206", 
              "https://doi.org/10.1038/35000501"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.onc.1201771", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1002190934", 
              "https://doi.org/10.1038/sj.onc.1201771"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/35006081", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1030124366", 
              "https://doi.org/10.1038/35006081"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s000110050295", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1008753230", 
              "https://doi.org/10.1007/s000110050295"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.onc.1204898", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1044611773", 
              "https://doi.org/10.1038/sj.onc.1204898"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.onc.1202980", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1014257409", 
              "https://doi.org/10.1038/sj.onc.1202980"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/23948", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1049122030", 
              "https://doi.org/10.1038/23948"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.onc.1203222", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1035605625", 
              "https://doi.org/10.1038/sj.onc.1203222"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.onc.1202351", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1026030264", 
              "https://doi.org/10.1038/sj.onc.1202351"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2002-04", 
        "datePublishedReg": "2002-04-01", 
        "description": "Key Points Nuclear factor of \u03baB (NF-\u03baB) is a transcriptional regulator that is made up of different protein dimers that bind a common sequence motif known as the \u03baB site. Although NF-\u03baB target genes have been most intensely studied for their involvement in immunity and inflammation, this transcription factor also regulates cell proliferation, apoptosis and cell migration. Therefore, it is not surprising that NF-\u03baB has been shown to be constitutively activated in several types of cancer cell. NF-\u03baB activity is tightly controlled by several regulatory proteins, and disruption of this process has been associated with various haematological malignancies, as well as epithelial tumours such as breast cancer.  A causal connection between inflammation and cancer has been suspected for many years. Because NF-\u03baB becomes activated in response to inflammatory stimuli and its constitutive activation has been associated with cancer, NF-\u03baB might also serve as the missing link between these two processes. Numerous inhibitors of NF-\u03baB are therefore under development or have been developed.  Because of the widespread importance of this factor, it has been difficult to develop NF-\u03baB inhibitors that act specifically in cancer cells. Learning more about the complicated process of NF-\u03baB regulation should lead to better therapeutic approaches to target the factor in specific cell types.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/nrc780", 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1029716", 
            "issn": [
              "1474-175X", 
              "1474-1768"
            ], 
            "name": "Nature Reviews Cancer", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "4", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "2"
          }
        ], 
        "keywords": [
          "common sequence motifs", 
          "NF-\u03baB target genes", 
          "cancer cells", 
          "specific cell types", 
          "NF-\u03baB", 
          "NF-\u03baB regulation", 
          "transcriptional regulators", 
          "sequence motifs", 
          "transcription factors", 
          "target genes", 
          "regulatory proteins", 
          "protein dimer", 
          "constitutive activation", 
          "\u03baB sites", 
          "numerous inhibitors", 
          "cell migration", 
          "cell types", 
          "NF-\u03baB activity", 
          "widespread importance", 
          "cell proliferation", 
          "nuclear factor", 
          "NF-\u03baB inhibitor", 
          "best therapeutic approach", 
          "haematological malignancies", 
          "epithelial tumors", 
          "breast cancer", 
          "inflammatory stimuli", 
          "therapeutic approaches", 
          "cells", 
          "cancer", 
          "inhibitors", 
          "innocent bystander", 
          "genes", 
          "regulator", 
          "protein", 
          "missing link", 
          "motif", 
          "inflammation", 
          "apoptosis", 
          "major culprit", 
          "regulation", 
          "proliferation", 
          "activation", 
          "\u03baB", 
          "disruption", 
          "complicated process", 
          "migration", 
          "dimers", 
          "factors", 
          "malignancy", 
          "tumors", 
          "sites", 
          "immunity", 
          "activity", 
          "involvement", 
          "process", 
          "types", 
          "key", 
          "response", 
          "culprit", 
          "causal connection", 
          "stimuli", 
          "years", 
          "bystanders", 
          "development", 
          "importance", 
          "link", 
          "approach", 
          "connection"
        ], 
        "name": "NF-\u03baB in cancer: from innocent bystander to major culprit", 
        "pagination": "301-310", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1024581782"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/nrc780"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "12001991"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/nrc780", 
          "https://app.dimensions.ai/details/publication/pub.1024581782"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-12-01T06:23", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_358.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/nrc780"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/nrc780'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/nrc780'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/nrc780'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/nrc780'


     

    This table displays all metadata directly associated to this object as RDF triples.

    267 TRIPLES      21 PREDICATES      124 URIs      94 LITERALS      14 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/nrc780 schema:about N7a34608bf7aa4f7a89fdc4265f0a7f0c
    2 N7e095bec52c34600ae77babc8243113c
    3 N7ebf338a6575484ba74408bae6d12b14
    4 N8b5f0a4cc2c14a9e89dead7e136e1c6f
    5 Naacce11974734e8588c0e92b0e919141
    6 Ne6a9f41c67874148984c95836fd55c49
    7 Nfd39539eb7d34c979d609495a35ea2d5
    8 anzsrc-for:11
    9 anzsrc-for:1112
    10 schema:author N22ebf73af22642a99f5389ac6fe0975f
    11 schema:citation sg:pub.10.1007/s000110050295
    12 sg:pub.10.1038/23948
    13 sg:pub.10.1038/35000501
    14 sg:pub.10.1038/35006081
    15 sg:pub.10.1038/35082500
    16 sg:pub.10.1038/7410
    17 sg:pub.10.1038/ni0302-221
    18 sg:pub.10.1038/nm0996-998
    19 sg:pub.10.1038/nrc703
    20 sg:pub.10.1038/sj.onc.1200895
    21 sg:pub.10.1038/sj.onc.1201771
    22 sg:pub.10.1038/sj.onc.1202351
    23 sg:pub.10.1038/sj.onc.1202717
    24 sg:pub.10.1038/sj.onc.1202833
    25 sg:pub.10.1038/sj.onc.1202980
    26 sg:pub.10.1038/sj.onc.1203018
    27 sg:pub.10.1038/sj.onc.1203222
    28 sg:pub.10.1038/sj.onc.1203412
    29 sg:pub.10.1038/sj.onc.1204162
    30 sg:pub.10.1038/sj.onc.1204257
    31 sg:pub.10.1038/sj.onc.1204898
    32 sg:pub.10.1038/sj.onc.1204901
    33 schema:datePublished 2002-04
    34 schema:datePublishedReg 2002-04-01
    35 schema:description Key Points Nuclear factor of κB (NF-κB) is a transcriptional regulator that is made up of different protein dimers that bind a common sequence motif known as the κB site. Although NF-κB target genes have been most intensely studied for their involvement in immunity and inflammation, this transcription factor also regulates cell proliferation, apoptosis and cell migration. Therefore, it is not surprising that NF-κB has been shown to be constitutively activated in several types of cancer cell. NF-κB activity is tightly controlled by several regulatory proteins, and disruption of this process has been associated with various haematological malignancies, as well as epithelial tumours such as breast cancer. A causal connection between inflammation and cancer has been suspected for many years. Because NF-κB becomes activated in response to inflammatory stimuli and its constitutive activation has been associated with cancer, NF-κB might also serve as the missing link between these two processes. Numerous inhibitors of NF-κB are therefore under development or have been developed. Because of the widespread importance of this factor, it has been difficult to develop NF-κB inhibitors that act specifically in cancer cells. Learning more about the complicated process of NF-κB regulation should lead to better therapeutic approaches to target the factor in specific cell types.
    36 schema:genre article
    37 schema:isAccessibleForFree false
    38 schema:isPartOf N502c2fff0f7a4d4fa3eb81a236033e42
    39 N9f26d0fa5f3344e0851133229bfa11d8
    40 sg:journal.1029716
    41 schema:keywords NF-κB
    42 NF-κB activity
    43 NF-κB inhibitor
    44 NF-κB regulation
    45 NF-κB target genes
    46 activation
    47 activity
    48 apoptosis
    49 approach
    50 best therapeutic approach
    51 breast cancer
    52 bystanders
    53 cancer
    54 cancer cells
    55 causal connection
    56 cell migration
    57 cell proliferation
    58 cell types
    59 cells
    60 common sequence motifs
    61 complicated process
    62 connection
    63 constitutive activation
    64 culprit
    65 development
    66 dimers
    67 disruption
    68 epithelial tumors
    69 factors
    70 genes
    71 haematological malignancies
    72 immunity
    73 importance
    74 inflammation
    75 inflammatory stimuli
    76 inhibitors
    77 innocent bystander
    78 involvement
    79 key
    80 link
    81 major culprit
    82 malignancy
    83 migration
    84 missing link
    85 motif
    86 nuclear factor
    87 numerous inhibitors
    88 process
    89 proliferation
    90 protein
    91 protein dimer
    92 regulation
    93 regulator
    94 regulatory proteins
    95 response
    96 sequence motifs
    97 sites
    98 specific cell types
    99 stimuli
    100 target genes
    101 therapeutic approaches
    102 transcription factors
    103 transcriptional regulators
    104 tumors
    105 types
    106 widespread importance
    107 years
    108 κB
    109 κB sites
    110 schema:name NF-κB in cancer: from innocent bystander to major culprit
    111 schema:pagination 301-310
    112 schema:productId N2b1c9831dadb450db20f1bdc474cfefc
    113 N6eba2ad8ae644351906ceb088a2312b8
    114 Nb2d3e02fe0b74f57ac838ef4022109c8
    115 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024581782
    116 https://doi.org/10.1038/nrc780
    117 schema:sdDatePublished 2022-12-01T06:23
    118 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    119 schema:sdPublisher N63412c6f1eec4e7687ccc8efc9c6e138
    120 schema:url https://doi.org/10.1038/nrc780
    121 sgo:license sg:explorer/license/
    122 sgo:sdDataset articles
    123 rdf:type schema:ScholarlyArticle
    124 N1dfa0b32ddc84287834b5f8c1ac212e6 rdf:first sg:person.01271704732.87
    125 rdf:rest rdf:nil
    126 N22ebf73af22642a99f5389ac6fe0975f rdf:first sg:person.0706540600.87
    127 rdf:rest N44df128eb7274f2fa6b597eb9b50cd67
    128 N2b1c9831dadb450db20f1bdc474cfefc schema:name pubmed_id
    129 schema:value 12001991
    130 rdf:type schema:PropertyValue
    131 N44df128eb7274f2fa6b597eb9b50cd67 rdf:first sg:person.01310256550.39
    132 rdf:rest N645f70e469da4293bf2aa272114ec67b
    133 N502c2fff0f7a4d4fa3eb81a236033e42 schema:issueNumber 4
    134 rdf:type schema:PublicationIssue
    135 N63412c6f1eec4e7687ccc8efc9c6e138 schema:name Springer Nature - SN SciGraph project
    136 rdf:type schema:Organization
    137 N645f70e469da4293bf2aa272114ec67b rdf:first sg:person.01356730670.31
    138 rdf:rest N1dfa0b32ddc84287834b5f8c1ac212e6
    139 N6eba2ad8ae644351906ceb088a2312b8 schema:name dimensions_id
    140 schema:value pub.1024581782
    141 rdf:type schema:PropertyValue
    142 N7a34608bf7aa4f7a89fdc4265f0a7f0c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    143 schema:name Humans
    144 rdf:type schema:DefinedTerm
    145 N7e095bec52c34600ae77babc8243113c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    146 schema:name Lymphatic Diseases
    147 rdf:type schema:DefinedTerm
    148 N7ebf338a6575484ba74408bae6d12b14 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    149 schema:name Animals
    150 rdf:type schema:DefinedTerm
    151 N8b5f0a4cc2c14a9e89dead7e136e1c6f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    152 schema:name Models, Biological
    153 rdf:type schema:DefinedTerm
    154 N9f26d0fa5f3344e0851133229bfa11d8 schema:volumeNumber 2
    155 rdf:type schema:PublicationVolume
    156 Naacce11974734e8588c0e92b0e919141 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    157 schema:name Neoplasms
    158 rdf:type schema:DefinedTerm
    159 Nb2d3e02fe0b74f57ac838ef4022109c8 schema:name doi
    160 schema:value 10.1038/nrc780
    161 rdf:type schema:PropertyValue
    162 Ne6a9f41c67874148984c95836fd55c49 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    163 schema:name NF-kappa B
    164 rdf:type schema:DefinedTerm
    165 Nfd39539eb7d34c979d609495a35ea2d5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    166 schema:name Signal Transduction
    167 rdf:type schema:DefinedTerm
    168 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    169 schema:name Medical and Health Sciences
    170 rdf:type schema:DefinedTerm
    171 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
    172 schema:name Oncology and Carcinogenesis
    173 rdf:type schema:DefinedTerm
    174 sg:journal.1029716 schema:issn 1474-175X
    175 1474-1768
    176 schema:name Nature Reviews Cancer
    177 schema:publisher Springer Nature
    178 rdf:type schema:Periodical
    179 sg:person.01271704732.87 schema:affiliation grid-institutes:grid.266100.3
    180 schema:familyName Li
    181 schema:givenName Zhi-Wei
    182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271704732.87
    183 rdf:type schema:Person
    184 sg:person.01310256550.39 schema:affiliation grid-institutes:grid.266100.3
    185 schema:familyName Cao
    186 schema:givenName Yixue
    187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01310256550.39
    188 rdf:type schema:Person
    189 sg:person.01356730670.31 schema:affiliation grid-institutes:grid.266100.3
    190 schema:familyName Greten
    191 schema:givenName Florian R.
    192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01356730670.31
    193 rdf:type schema:Person
    194 sg:person.0706540600.87 schema:affiliation grid-institutes:grid.266100.3
    195 schema:familyName Karin
    196 schema:givenName Michael
    197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0706540600.87
    198 rdf:type schema:Person
    199 sg:pub.10.1007/s000110050295 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008753230
    200 https://doi.org/10.1007/s000110050295
    201 rdf:type schema:CreativeWork
    202 sg:pub.10.1038/23948 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049122030
    203 https://doi.org/10.1038/23948
    204 rdf:type schema:CreativeWork
    205 sg:pub.10.1038/35000501 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010898206
    206 https://doi.org/10.1038/35000501
    207 rdf:type schema:CreativeWork
    208 sg:pub.10.1038/35006081 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030124366
    209 https://doi.org/10.1038/35006081
    210 rdf:type schema:CreativeWork
    211 sg:pub.10.1038/35082500 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034302480
    212 https://doi.org/10.1038/35082500
    213 rdf:type schema:CreativeWork
    214 sg:pub.10.1038/7410 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016228251
    215 https://doi.org/10.1038/7410
    216 rdf:type schema:CreativeWork
    217 sg:pub.10.1038/ni0302-221 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045237056
    218 https://doi.org/10.1038/ni0302-221
    219 rdf:type schema:CreativeWork
    220 sg:pub.10.1038/nm0996-998 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014827861
    221 https://doi.org/10.1038/nm0996-998
    222 rdf:type schema:CreativeWork
    223 sg:pub.10.1038/nrc703 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029485597
    224 https://doi.org/10.1038/nrc703
    225 rdf:type schema:CreativeWork
    226 sg:pub.10.1038/sj.onc.1200895 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026178102
    227 https://doi.org/10.1038/sj.onc.1200895
    228 rdf:type schema:CreativeWork
    229 sg:pub.10.1038/sj.onc.1201771 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002190934
    230 https://doi.org/10.1038/sj.onc.1201771
    231 rdf:type schema:CreativeWork
    232 sg:pub.10.1038/sj.onc.1202351 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026030264
    233 https://doi.org/10.1038/sj.onc.1202351
    234 rdf:type schema:CreativeWork
    235 sg:pub.10.1038/sj.onc.1202717 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017468422
    236 https://doi.org/10.1038/sj.onc.1202717
    237 rdf:type schema:CreativeWork
    238 sg:pub.10.1038/sj.onc.1202833 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021502107
    239 https://doi.org/10.1038/sj.onc.1202833
    240 rdf:type schema:CreativeWork
    241 sg:pub.10.1038/sj.onc.1202980 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014257409
    242 https://doi.org/10.1038/sj.onc.1202980
    243 rdf:type schema:CreativeWork
    244 sg:pub.10.1038/sj.onc.1203018 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043782984
    245 https://doi.org/10.1038/sj.onc.1203018
    246 rdf:type schema:CreativeWork
    247 sg:pub.10.1038/sj.onc.1203222 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035605625
    248 https://doi.org/10.1038/sj.onc.1203222
    249 rdf:type schema:CreativeWork
    250 sg:pub.10.1038/sj.onc.1203412 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046200001
    251 https://doi.org/10.1038/sj.onc.1203412
    252 rdf:type schema:CreativeWork
    253 sg:pub.10.1038/sj.onc.1204162 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031069682
    254 https://doi.org/10.1038/sj.onc.1204162
    255 rdf:type schema:CreativeWork
    256 sg:pub.10.1038/sj.onc.1204257 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043172496
    257 https://doi.org/10.1038/sj.onc.1204257
    258 rdf:type schema:CreativeWork
    259 sg:pub.10.1038/sj.onc.1204898 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044611773
    260 https://doi.org/10.1038/sj.onc.1204898
    261 rdf:type schema:CreativeWork
    262 sg:pub.10.1038/sj.onc.1204901 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011576997
    263 https://doi.org/10.1038/sj.onc.1204901
    264 rdf:type schema:CreativeWork
    265 grid-institutes:grid.266100.3 schema:alternateName Department of Pharmacology, Laboratory of Gene Regulation and Signal Transduction, School of Medicine, University of California San Diego, 9500 Gilman Drive, 92093, La Jolla, California, USA
    266 schema:name Department of Pharmacology, Laboratory of Gene Regulation and Signal Transduction, School of Medicine, University of California San Diego, 9500 Gilman Drive, 92093, La Jolla, California, USA
    267 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...